Xiaowei Chang - Jun 7, 2023 Form 4 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Xiaowei Chang
Stock symbol
AMAM
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 04:11 PM
Previous filing
Jan 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMAM Cash-Settled RSU's Award $0 -85K -50% $0.00 85K Jun 7, 2023 Ordinary Shares 85K Direct F1, F2
transaction AMAM Cash-Settled RSU's Award $0 -125K -50% $0.00 125K Jun 7, 2023 Ordinary Shares 125K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units (the "RSUs") payable solely in cash based on the market price of the underlying Ordinary Shares on the vesting date (the reporting person will never receive the Ordinary Shares).
F2 The RSUs vest on the earlier of (i) the one year anniversary of the date of grant and (ii) the day before the next annual general meeting.
F3 The RSUs vest in three (3) successive equal annual installments following June 8, 2023.